Search terms

Home
Philips
Turbo-Elite Laser atherectomy catheter

Turbo-Elite

Laser atherectomy catheter

Find similar products

Turbo-Elite laser atherectomy catheter captures the power of ultraviolet light to provide a versatile and reliable tool for treating multiple lesion morphologies within PAD lesions. By working at the molecular level through three unique mechanisms of action, Turbo-Elite is capable of powering through the most challenging restenoses and occlusions.

Contact us
Features
Versatile performance

Versatile performance

Turbo-Elite uniformly and reliably helps treat a variety of morphologies and locations with a single catheter.
Cross and debulk with one device

Cross and debulk with one device

The safe and proven step-by-step method crosses and prepares challenging occlusions without a wire by acting directly from the catheter’s tip.³
Reliably simple

Reliably simple

With its safe and easy-to-use technology, Turbo-Elite provides laser-accurate control with none of the moving parts or cutting blades of competing atherectomy catheters.
Strong clinical support

Strong clinical support

Turbo-Elite has a proven record of safety and effectiveness with results that consistently demonstrate an ability to save limbs and treat lesions both above and below the knee.¹⁻⁴
Cost-effective solution

Cost-effective solution

Through a single device that can both cross and debulk a lesion, Turbo-Elite provides you with clinical efficacy and reliability at a lower cost per case than other technologies.
  • 1. Dippel et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther. 2009 Dec;16(6):665-75.
  • 2. Zeller et al. J Endovasc Ther. Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study. J Endovasc Ther. 2014 Feb;21(1):52-60
  • 3. Dippel et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):92-101
  • 4. Laird et al.  Limb Salvage Following Laser-Assisted Angioplasty for Critical Limb Ischemia: Results of the LACI Multi­center Trial. J Endovasc Ther. 2006 Feb;13(1):1-11
  • *When used with Turbo-Tandem and PTA
  • **Images courtesy of Dr. Devendra Amin

By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.

I understand